Why Elevance Health, Inc.’s (ELV) Stock Is Down 5.98%
As of Wednesday, November 18, Elevance Health, Inc.’s ELV share price has dipped by 5.98%, which has investors questioning if this is right time to buy.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Rosalio Madrigal
Rosalio Madrigal
Michael Rose
Rosalio Madrigal
| Share Statistics | ELV | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $93,753.1 | $1,953.4 | 97% |
|
| Shares Out (Mil) | 217.6 | 80.6 | 77% |
|
| Institutional Ownership | 99.9% | 87.3% | 96% |
|
| Float (Mil) | 215.6 | 58.7 | 75% |
|
| Beta | 0.63 | 0.75 | 36% |
|
| Avg Daily Volume (000s) | 1,347 | 658 | 73% |
|
| Price Change (52-week) |
33.2% | 81.4% | 79% |
|
| Growth | ELV | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 10.3% | 10.4% | 59% |
|
| Net Income (5yr) | 4.4% | (0.5%) | 47% |
|
| EPS (5yr) | 7.0% | 3.0% | 42 |
|
| Dividends (5yr) | 12.5% | 0.0% | 99% |
|
| Cash Flow (5yr) | 10.8% | (17.4%) | 70% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 20 | 21 | 21 | |
| Current EPS | $2.067 | $29.138 | $30.286 | |
| Month Ago EPS | $2.438 | $27.244 | $29.600 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $2.468 | $27.158 | $29.634 | |
| Year/Year Chg | (67.0%) | 15.6% | 37.1% | |
| Financials | ELV | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $201,832 | $1,529 | 100% |
|
| Net Income (TTM) (Mil) | $5,139 | $33 | 97% |
|
| EPS (TTM) | $23.509 | $0.300 | 98% |
|
| Operating Cash Flow (TTM) (Mil) | $7,596 | $175 | 97% |
|
| Net Cash Flow (TTM) (Mil) | $1,635 | $7 | 96% |
|
| Long-Term Debt (Q1) (Mil) | $30,382 | $419 | 97% |
|
| Enterprise Value (Q1) (Mil) | $113,359 | $2,427 | 97% |
|
| Valuation | ELV | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.10 | 2.83 | 58% |
|
| P/E | 18.5 | 27.6 | 51% |
|
| Dividend Yield | 1.6% | 0.0% | 72% |
|
| PEG (5yr hist) | 2.6 | 1.2 | 77% |
|
| Ratios | ELV | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 26.4% | 27.3% | 30% |
|
| Net Margin | 2.5% | 1.4% | 38% |
|
| ROA | 4.1% | 2.4% | 66% |
|
| ROE | 11.6% | 7.3% | 61% |
|
| Liabilities to Assets | 65.0% | 61.5% | 60% |
|
| F-Score | 6 | 5 | 67% |
|
Passing Stock Screens
As of 11/17/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 13.2% |
| +/- S&P 500: | +5.8 |
| Performance Since Inception: | 13.6% |
| +/- S&P 500: | +6.2 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors